The U.S. Federal Drug and Food Administration (FDA) approved remdesivir to treat children for a COVID-19 infection. It can be administered to patients as young as 28 days old who weigh about seven pounds. This is the first approved drug to treat COVID-19 in those under 12. Remdesivir is an injection. A child must be […]
The post Remdesivir Approval First COVID Treatment for Children Under 12 appeared first on Guardian Liberty Voice.